Pharmaceutical compositions and method of using levodopa and carbidopa

Details for Australian Patent Application No. 2004270174 (hide)

International Classifications

Event Publications

23 February 2006 PCT application entered the National Phase

PCT publication WO2005/023185 Priority application(s): WO2005/023185

20 May 2010 Application Accepted

Published as AU-B-2004270174

12 August 2010 Application for Amendment

The nature of the amendment is: Amend co-inventor name from Almarsson, Om to Almarsson, Orn.. Address for service in Australia - Wrays 56 Ord Street West Perth WA 6005 2004278030 2,4-Dioxo-3-quinazolinylaryl sulfonylureas Portola Pharmaceuticals, Inc. The nature of the amendment is as shown in the statement(s) filed 15 Jul 2010. Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 14, ANZ Centre 324 Queen Street Brisbane QLD 4000

9 December 2010 Amendment Made

The nature of the amendment is: Amend co-inventor name from Almarsson, Om to Almarsson, Orn

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.